[1]
E. Jachimczak, “BLINATUMOMAB IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA: MECHANISM OF ACTION, CLINICAL RELEVANCE, AND EMERGING THERAPEUTIC PERSPECTIVES”, IJITSS, vol. 3, no. 2(50), Jun. 2026, doi: 10.31435/ijitss.2(50).2026.5637.